Bioelectronics 

$0
7
+$0+16.67% Wednesday 19:09

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
4,300,012
Avg. Volume
17,133,462
Mkt Cap
8.65M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

15AugExpected
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
0

Financials

-101.12%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
1.43MRevenue
-1.45MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIEL. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare, offering products that compete directly with Bioelectronics' pain management devices.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc is a global leader in medical technology, services, and solutions, including pain management devices that rival Bioelectronics' offerings.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including pain management solutions.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories operates in various healthcare segments, including chronic pain management devices, competing with Bioelectronics' products.
Smith & Nephew
SNN
Mkt Cap13.72B
Smith & Nephew plc offers advanced medical devices in orthopaedics, including products for pain relief, directly competing with Bioelectronics.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of healthcare products, including pain management solutions.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation is one of the world's leading medical technology companies, offering products for pain management that compete with Bioelectronics.
Edwards Lifesciences
EW
Mkt Cap47.07B
Edwards Lifesciences Corporation specializes in patient-focused medical innovations for structural heart disease, also venturing into pain management solutions.
Hologic
HOLX
Mkt Cap16.89B
Hologic, Inc. focuses on women's health and well-being, but its expansion into healthcare solutions broadly competes with Bioelectronics' pain management devices.

About

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.
Show more...
CEO
Mr. Andrew J. Whelan
Employees
9
Country
US
ISIN
US09062H1086

Listings

0 Comments

Share your thoughts

FAQ

What is Bioelectronics stock price today?
The current price of BIEL is $0 USD — it has increased by +16.67% in the past 24 hours. Watch Bioelectronics stock price performance more closely on the chart.
What is Bioelectronics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bioelectronics stocks are traded under the ticker BIEL.
Is Bioelectronics stock price growing?
BIEL stock has risen by +16.67% compared to the previous week, the month change is a +16.67% rise, over the last year Bioelectronics has showed a +250% increase.
What is Bioelectronics market cap?
Today Bioelectronics has the market capitalization of 8.65M
What were Bioelectronics earnings last quarter?
BIEL earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bioelectronics revenue for the last year?
Bioelectronics revenue for the last year amounts to 1.43M USD.
What is Bioelectronics net income for the last year?
BIEL net income for the last year is -1.45M USD.
How many employees does Bioelectronics have?
As of April 09, 2026, the company has 9 employees.
In which sector is Bioelectronics located?
Bioelectronics operates in the Health Care sector.
When did Bioelectronics complete a stock split?
Bioelectronics has not had any recent stock splits.
Where is Bioelectronics headquartered?
Bioelectronics is headquartered in Frederick, US.